17-BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME

PCT No. PCT/HU93/00058 Sec. 371 Date Mar. 23, 1995 Sec. 102(e) Date Mar. 23, 1995 PCT Filed Oct. 1, 1993 PCT Pub. No. WO94/07909 PCT Pub. Date Apr. 14, 1994The invention relates to novel 17 beta -substituted 4-azaandrostane derivatives of general formula (I), (I) wherein R means hydrogen or a C1-3al...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CSEHI ATTILA, BALOGH GABOR, SZPORNY LASZLO, TUBA ZOLTAN, LOVASNE MARSAI M, HORVATH JUDIT, HAJOS GYORGY, KOLLAR LASZLO, JAVOR ANDRAS
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CSEHI ATTILA
BALOGH GABOR
SZPORNY LASZLO
TUBA ZOLTAN
LOVASNE MARSAI M
HORVATH JUDIT
HAJOS GYORGY
KOLLAR LASZLO
JAVOR ANDRAS
description PCT No. PCT/HU93/00058 Sec. 371 Date Mar. 23, 1995 Sec. 102(e) Date Mar. 23, 1995 PCT Filed Oct. 1, 1993 PCT Pub. No. WO94/07909 PCT Pub. Date Apr. 14, 1994The invention relates to novel 17 beta -substituted 4-azaandrostane derivatives of general formula (I), (I) wherein R means hydrogen or a C1-3alkyl group; R1 and R2 are the same or different and stand for hydrogen or a C1-4alkyl group with the proviso that both can mean hydrogen only in the case when n is higher than 5; or R1 and R2 together means an alpha , omega -alkylene group containing 5 to 7 carbon atoms, the terminal carbon atoms of said alkylene group being bound to the same ring carbon atom; n is 4, 5, 6 or 7; and +E,uns ---+EE bond line represents a single or double bond. Furthermore, the invention relates to pharmaceutical composition containing these compounds as well as a process for the preparation of the compounds of general formula (I). The compounds of general formula (I) exert a 5 alpha -reductase enzyme-inhibiting effect and therefore, they are useful for treating all diseases, where the aim is to reduce the tissue dihydrotestosterone level, such as the benign prostatic hyperplasia, acne, seborrhoea, female hirsutism or androgenic alopecia.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SK40895A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SK40895A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SK40895A33</originalsourceid><addsrcrecordid>eNqFjL0KwkAQhNNYiPoKcg_ggZKIWm4uG3Po_XC7SWETgpyVaCB2vrwR7K1mPuZjpsl7s5M5Mkiqc2LNNWMhMgkXAFsERwwWRYFBN8C6QVoJX0EwoLBmreAslDPekWbtLI1gGbTV9ii4QiPGD-GDU0gkShfGjh7CdyYwOE8mt-4-xMUvZ8myRFaVjP2zjUPfXeMjvlo6Zev9YQtp-lf4ABK7OfU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>17-BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME</title><source>esp@cenet</source><creator>CSEHI ATTILA ; BALOGH GABOR ; SZPORNY LASZLO ; TUBA ZOLTAN ; LOVASNE MARSAI M ; HORVATH JUDIT ; HAJOS GYORGY ; KOLLAR LASZLO ; JAVOR ANDRAS</creator><creatorcontrib>CSEHI ATTILA ; BALOGH GABOR ; SZPORNY LASZLO ; TUBA ZOLTAN ; LOVASNE MARSAI M ; HORVATH JUDIT ; HAJOS GYORGY ; KOLLAR LASZLO ; JAVOR ANDRAS</creatorcontrib><description>PCT No. PCT/HU93/00058 Sec. 371 Date Mar. 23, 1995 Sec. 102(e) Date Mar. 23, 1995 PCT Filed Oct. 1, 1993 PCT Pub. No. WO94/07909 PCT Pub. Date Apr. 14, 1994The invention relates to novel 17 beta -substituted 4-azaandrostane derivatives of general formula (I), (I) wherein R means hydrogen or a C1-3alkyl group; R1 and R2 are the same or different and stand for hydrogen or a C1-4alkyl group with the proviso that both can mean hydrogen only in the case when n is higher than 5; or R1 and R2 together means an alpha , omega -alkylene group containing 5 to 7 carbon atoms, the terminal carbon atoms of said alkylene group being bound to the same ring carbon atom; n is 4, 5, 6 or 7; and +E,uns ---+EE bond line represents a single or double bond. Furthermore, the invention relates to pharmaceutical composition containing these compounds as well as a process for the preparation of the compounds of general formula (I). The compounds of general formula (I) exert a 5 alpha -reductase enzyme-inhibiting effect and therefore, they are useful for treating all diseases, where the aim is to reduce the tissue dihydrotestosterone level, such as the benign prostatic hyperplasia, acne, seborrhoea, female hirsutism or androgenic alopecia.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; STEROIDS</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950711&amp;DB=EPODOC&amp;CC=SK&amp;NR=40895A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950711&amp;DB=EPODOC&amp;CC=SK&amp;NR=40895A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CSEHI ATTILA</creatorcontrib><creatorcontrib>BALOGH GABOR</creatorcontrib><creatorcontrib>SZPORNY LASZLO</creatorcontrib><creatorcontrib>TUBA ZOLTAN</creatorcontrib><creatorcontrib>LOVASNE MARSAI M</creatorcontrib><creatorcontrib>HORVATH JUDIT</creatorcontrib><creatorcontrib>HAJOS GYORGY</creatorcontrib><creatorcontrib>KOLLAR LASZLO</creatorcontrib><creatorcontrib>JAVOR ANDRAS</creatorcontrib><title>17-BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME</title><description>PCT No. PCT/HU93/00058 Sec. 371 Date Mar. 23, 1995 Sec. 102(e) Date Mar. 23, 1995 PCT Filed Oct. 1, 1993 PCT Pub. No. WO94/07909 PCT Pub. Date Apr. 14, 1994The invention relates to novel 17 beta -substituted 4-azaandrostane derivatives of general formula (I), (I) wherein R means hydrogen or a C1-3alkyl group; R1 and R2 are the same or different and stand for hydrogen or a C1-4alkyl group with the proviso that both can mean hydrogen only in the case when n is higher than 5; or R1 and R2 together means an alpha , omega -alkylene group containing 5 to 7 carbon atoms, the terminal carbon atoms of said alkylene group being bound to the same ring carbon atom; n is 4, 5, 6 or 7; and +E,uns ---+EE bond line represents a single or double bond. Furthermore, the invention relates to pharmaceutical composition containing these compounds as well as a process for the preparation of the compounds of general formula (I). The compounds of general formula (I) exert a 5 alpha -reductase enzyme-inhibiting effect and therefore, they are useful for treating all diseases, where the aim is to reduce the tissue dihydrotestosterone level, such as the benign prostatic hyperplasia, acne, seborrhoea, female hirsutism or androgenic alopecia.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>STEROIDS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjL0KwkAQhNNYiPoKcg_ggZKIWm4uG3Po_XC7SWETgpyVaCB2vrwR7K1mPuZjpsl7s5M5Mkiqc2LNNWMhMgkXAFsERwwWRYFBN8C6QVoJX0EwoLBmreAslDPekWbtLI1gGbTV9ii4QiPGD-GDU0gkShfGjh7CdyYwOE8mt-4-xMUvZ8myRFaVjP2zjUPfXeMjvlo6Zev9YQtp-lf4ABK7OfU</recordid><startdate>19950711</startdate><enddate>19950711</enddate><creator>CSEHI ATTILA</creator><creator>BALOGH GABOR</creator><creator>SZPORNY LASZLO</creator><creator>TUBA ZOLTAN</creator><creator>LOVASNE MARSAI M</creator><creator>HORVATH JUDIT</creator><creator>HAJOS GYORGY</creator><creator>KOLLAR LASZLO</creator><creator>JAVOR ANDRAS</creator><scope>EVB</scope></search><sort><creationdate>19950711</creationdate><title>17-BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME</title><author>CSEHI ATTILA ; BALOGH GABOR ; SZPORNY LASZLO ; TUBA ZOLTAN ; LOVASNE MARSAI M ; HORVATH JUDIT ; HAJOS GYORGY ; KOLLAR LASZLO ; JAVOR ANDRAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SK40895A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1995</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>STEROIDS</topic><toplevel>online_resources</toplevel><creatorcontrib>CSEHI ATTILA</creatorcontrib><creatorcontrib>BALOGH GABOR</creatorcontrib><creatorcontrib>SZPORNY LASZLO</creatorcontrib><creatorcontrib>TUBA ZOLTAN</creatorcontrib><creatorcontrib>LOVASNE MARSAI M</creatorcontrib><creatorcontrib>HORVATH JUDIT</creatorcontrib><creatorcontrib>HAJOS GYORGY</creatorcontrib><creatorcontrib>KOLLAR LASZLO</creatorcontrib><creatorcontrib>JAVOR ANDRAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CSEHI ATTILA</au><au>BALOGH GABOR</au><au>SZPORNY LASZLO</au><au>TUBA ZOLTAN</au><au>LOVASNE MARSAI M</au><au>HORVATH JUDIT</au><au>HAJOS GYORGY</au><au>KOLLAR LASZLO</au><au>JAVOR ANDRAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>17-BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME</title><date>1995-07-11</date><risdate>1995</risdate><abstract>PCT No. PCT/HU93/00058 Sec. 371 Date Mar. 23, 1995 Sec. 102(e) Date Mar. 23, 1995 PCT Filed Oct. 1, 1993 PCT Pub. No. WO94/07909 PCT Pub. Date Apr. 14, 1994The invention relates to novel 17 beta -substituted 4-azaandrostane derivatives of general formula (I), (I) wherein R means hydrogen or a C1-3alkyl group; R1 and R2 are the same or different and stand for hydrogen or a C1-4alkyl group with the proviso that both can mean hydrogen only in the case when n is higher than 5; or R1 and R2 together means an alpha , omega -alkylene group containing 5 to 7 carbon atoms, the terminal carbon atoms of said alkylene group being bound to the same ring carbon atom; n is 4, 5, 6 or 7; and +E,uns ---+EE bond line represents a single or double bond. Furthermore, the invention relates to pharmaceutical composition containing these compounds as well as a process for the preparation of the compounds of general formula (I). The compounds of general formula (I) exert a 5 alpha -reductase enzyme-inhibiting effect and therefore, they are useful for treating all diseases, where the aim is to reduce the tissue dihydrotestosterone level, such as the benign prostatic hyperplasia, acne, seborrhoea, female hirsutism or androgenic alopecia.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_SK40895A3
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
title 17-BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A38%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CSEHI%20ATTILA&rft.date=1995-07-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESK40895A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true